Literature DB >> 2283573

Pain in children and adolescents with sickle cell disease: a descriptive study.

G A Walco1, C D Dampier.   

Abstract

In sickle cell disease, vaso-occlusion in the small blood vessels leads to bone or joint pain which is variable in intensity and duration. An essential first step toward the development of specific treatment guidelines for such painful episodes in children and adolescents is the accurate evaluation of pain. The systematic assessment of vaso-occlusive pain is addressed through two separate studies. In the first, 35 pediatric sickle cell disease patients between 5 and 16 years of age were evaluated in an outpatient clinic with the Varni/Thompson Pediatric Pain Questionnaire. In the second, data were gathered over the course of hospitalizations for uncomplicated vaso-occlusive episodes in 17 adolescent patients. Results showed that this pain experience can be quantified, that vaso-occlusive pain spans a broad range of intensity levels, and that there are a number of socioemotional factors associated with the pain experience. Further research to systematically assess the psychometric properties of pain assessment instrument is recommended.

Entities:  

Mesh:

Year:  1990        PMID: 2283573     DOI: 10.1093/jpepsy/15.5.643

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  29 in total

1.  Pain intensity, psychological inflexibility, and acceptance of pain as predictors of functioning in adolescents with juvenile idiopathic arthritis: a preliminary investigation.

Authors:  Amanda B Feinstein; Evan M Forman; Akihiko Masuda; Lindsey L Cohen; James D Herbert; L Nandini Moorthy; Donald P Goldsmith
Journal:  J Clin Psychol Med Settings       Date:  2011-09

2.  Evaluation and Treatment of Sickle Cell Pain in the Emergency Department: Paths to a Better Future.

Authors:  William T Zempsky
Journal:  Clin Pediatr Emerg Med       Date:  2010-12-01

Review 3.  Evidence-based assessment of pediatric pain.

Authors:  Lindsey L Cohen; Kathleen Lemanek; Ronald L Blount; Lynnda M Dahlquist; Crystal S Lim; Tonya M Palermo; Kristine D McKenna; Karen E Weiss
Journal:  J Pediatr Psychol       Date:  2007-11-17

4.  A QST-based Pain Phenotype in Adults With Sickle Cell Disease: Sensitivity and Specificity of Quality Descriptors.

Authors:  Brenda W Dyal; Miriam O Ezenwa; Saunjoo L Yoon; Roger B Fillingim; Yingwei Yao; Judith M Schlaeger; Marie L Suarez; Zaijie J Wang; Robert E Molokie; Diana J Wilkie
Journal:  Pain Pract       Date:  2019-10-18       Impact factor: 3.183

5.  Assessment of pain in patients with juvenile rheumatoid arthritis: relation between pain intensity and degree of joint inflammation.

Authors:  N T Ilowite; G A Walco; R Pochaczevsky
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

6.  Pain charts (body maps or manikins) in assessment of the location of pediatric pain.

Authors:  Carl L von Baeyer; Vivian Lin; Laura C Seidman; Jennie Ci Tsao; Lonnie K Zeltzer
Journal:  Pain Manag       Date:  2011-01

7.  Relationship between resting blood pressure and laboratory-induced pain among healthy children.

Authors:  Kelly Haas; Qian Lu; Subhadra Evans; Jennie C I Tsao; Lonnie K Zeltzer
Journal:  Gend Med       Date:  2011-10-28

8.  Predictive Ability of Intermittent Daily Sickle Cell Pain Assessment: The PiSCES Project.

Authors:  Wally R Smith; Donna K McClish; James Levenson; Imoigele Aisiku; Bassam Dahman; Viktor E Bovbjerg; Susan Roseff; John Roberts
Journal:  Pain Med       Date:  2018-10-01       Impact factor: 3.750

Review 9.  Key Components of Pain Management for Children and Adults with Sickle Cell Disease.

Authors:  Amanda M Brandow; Michael R DeBaun
Journal:  Hematol Oncol Clin North Am       Date:  2018-06       Impact factor: 3.722

10.  Clinically meaningful measurement of pain in children with sickle cell disease.

Authors:  Matthew P Myrvik; Amanda M Brandow; Amy L Drendel; Ke Yan; Raymond G Hoffmann; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2013-06-17       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.